Scientific News Boston Scientific Resumes Enrolment In Pulsed Field Ablation Trial
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific Resumes Enrolment In Pulsed Field Ablation Trial is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific claims European approval for Farapoint focal pulsed field ablation catheter
Boston Scientific has obtained an approval in Europe for the latest addition to its pulsed field ablation portfolio, with the Farapoint focal catheter. | The CE Mark adds the treatment of right atrial ... Read More
Boston Scientific sustains momentum in the PFA market: What's next?
Atrial fibrillation (AF or AFib) is one of the most common abnormal heart rhythms, affecting nearly 38 million people worldwide — a figure projected to nearly triple by 2030. Boston Scientific BSX ... Read More
Boston Scientific gets European nod for Farapoint catheter
Boston Scientific (NYSE: BSX) announced recently that it received CE mark for its Farapoint pulsed field ablation (PFA) catheter. Read More
Boston Scientific Secures CE Mark for Farapoint Catheter, Strengthening Position in PFA
Boston Scientific faces intense competition from major players such as Medtronic, Johnson & Johnson, and Abbott Laboratories. Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus